{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-24-000125","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.797516+00:00","generated_at":"2026-05-31T20:58:53.199379+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Emergent BioSolutions grants 15,000 RSUs to EVP Jennifer Fox for strategic contributions","bullets":["Jennifer Fox, EVP External Affairs, General Counsel, and Corporate Secretary, receives 15,000 restricted stock units.","Award vests on first anniversary of grant date, contingent on continued employment.","Special one-time discretionary award approved by Compensation Committee on July 11, 2024.","Award recognizes Fox's substantial contributions to executing recent strategic initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-24-000125","json":"https://secwatch.observer/filing/0001367644-24-000125.json","markdown":"https://secwatch.observer/filing/0001367644-24-000125.md","text":"https://secwatch.observer/filing/0001367644-24-000125.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000125/0001367644-24-000125-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000125/ebs-20240711.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:58:53.199379+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}